A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects

NCT07185113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male

Interventions

DRUG: GEn-1124

Sponsor

GEn1E Lifesciences

Collaborators

[object Object]